404
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Prediction of chemotherapy adverse reactions and mortality in older patients with primary lung cancer through frailty index based on routine laboratory data

, , , , &
Pages 1187-1197 | Published online: 05 Jul 2019

References

  • Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people and implications for health policy and practice. Lancet (London, England). 2015;385(9967):549–562. doi:10.1016/s0140-6736(14)61347-7
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
  • Walters S, Maringe C, Coleman MP, et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007. Thorax. 2013;68(6):551–564. doi:10.1136/thoraxjnl-2012-20229723399908
  • Eberhardt WE, De Ruysscher D, Weder W, et al. 2nd ESMO consensus conference in lung cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol. 2015;26(8):1573–1588. doi:10.1093/annonc/mdv18725897013
  • Shrestha S, Shrestha S, Khanal S. Establishment of the first cancer hospital-based pharmacovigilance center in Nepal. Res Social Adm Pharm. 2018;14(11):1088–1089. doi:10.1016/j.sapharm.2018.07.017s30064898
  • Petrelli F, Barni S. Non-cancer-related mortality after cisplatin-based adjuvant chemotherapy for non-small cell lung cancer: a study-level meta-analysis of 16 randomized trials. Med Oncol. 2013;30(3):641. doi:10.1007/s12032-013-0641-523813019
  • Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The Lancet. 2013;381(9868):752–762. doi:10.1016/s0140-6736(12)62167-9
  • Ethun CG, Bilen MA, Jani AB, et al. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin. 2017;67(5):362–377. doi:10.3322/caac.2140628731537
  • Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26(6):1091–1101. doi:10.1093/annonc/mdu54025403592
  • Cohen HJ, Smith D, Sun CL, et al. Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy. Cancer. 2016;122(24):3865–3872. doi:10.1002/cncr.3026927529755
  • Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010;58(4):681–687. doi:10.1111/j.1532-5415.2010.02764.x20345864
  • Theou O, Sluggett JK, Bell JS, et al. Frailty, hospitalization, and mortality in residential aged care. J Gerontology Series A, Biol Sci Med Sci. 2018;73(8):1090–1096. doi:10.1093/gerona/glx185
  • Theou O, Campbell S, Malone ML, Rockwood K. Older adults in the emergency department with frailty. Clin Geriatr Med. 2018;34(3):369–386. doi:10.1016/j.cger.2018.04.00330031422
  • Howlett SE, Rockwood MR, Mitnitski A, et al. Standard laboratory tests to identify older adults at increased risk of death. BMC Med. 2014;12:171. doi:10.1186/s12916-014-0171-925288274
  • Blodgett JM, Theou O, Howlett SE, Rockwood K. A frailty index from common clinical and laboratory tests predicts increased risk of death across the life course. GeroScience. 2017. doi:10.1007/s11357-017-9993-7
  • Rockwood K, McMillan M, Mitnitski A, Howlett SE. A frailty index based on common laboratory tests in comparison with a clinical frailty index for older adults in long-term care facilities. J Am Med Dir Assoc. 2015;16(10):842–847. doi:10.1016/j.jamda.2015.03.02725952475
  • Ritt M, Jager J, Ritt JI, Sieber CC, Gaßmann K-G. Operationalizing a frailty index using routine blood and urine tests. Clin Interv Aging. 2017;12:1029–1040. doi:10.2147/cia.S13198728721031
  • Blodgett JM, Theou O, Howlett SE, Wu FCW, Rockwood K. A frailty index based on laboratory deficits in community-dwelling men predicted their risk of adverse health outcomes. Age Ageing. 2016;45(4):463–468. doi:10.1093/ageing/afw05427076524
  • Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8(24). doi:10.1186/1471-2318-8-24
  • Franco I, Chen YH, Chipidza F, et al. Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy. J Geriatr Oncol. 2018;9(2):130–137. doi:10.1016/j.jgo.2017.09.00228941581
  • Portal D, Hofstetter L, Eshed I, et al. L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients. Cancer Manag Res. 2019;11(2579–2588). doi:10.2147/cmar.S195869
  • Raghavan G, Shaverdian N, Chan S, Chu F-I, Lee P. Comparing outcomes of patients with early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy based on frailty status. Clin Lung Cancer. 2018;19(5):e759–e66. doi:10.1016/j.cllc.2018.05.00829954680
  • Klausen HH, Petersen J, Bandholm T, et al. Association between routine laboratory tests and long-term mortality among acutely admitted older medical patients: a cohort study. BMC Geriatr. 2017;17(1):62. doi:10.1186/s12877-017-0434-328249621
  • Baijal P, Periyakoil V. Understanding frailty in cancer patients. Cancer J. 2014;20(5):358–366. doi:10.1097/ppo.000000000000006825299146
  • Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA. Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol. 2010;28(3):380–386. doi:10.1200/jco.2009.23.544020008637
  • Pallis AG, Gridelli C, Wedding U, et al. Management of elderly patients with NSCLC; updated expert’s opinion paper: EORTC elderly task force, lung cancer group and international society for geriatric oncology. Ann Oncol. 2014;25(7):1270–1283. doi:10.1093/annonc/mdu02224638905
  • Ommundsen N, Wyller TB, Nesbakken A, et al. Frailty is an independent predictor of survival in older patients with colorectal cancer. Oncologist. 2014;19(12):1268–1275. doi:10.1634/theoncologist.2014-023725355846
  • Tegels JJ, de Maat MF, Hulsewe KW, Hoofwijk AGM, Stoot JHMB. Value of geriatric frailty and nutritional status assessment in predicting postoperative mortality in gastric cancer surgery. J Gastrointestinal Surg. 2014:18(3):439–445. discussion 45-6. doi:10.1007/s11605-013-2443-7.
  • Fujisawa Y, Yoshino K, Otsuka A, et al. Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab. J Dermatol Sci. 2017;88(2):225–231. doi:10.1016/j.jdermsci.2017.07.00728736218
  • Cui MM, Li N, Liu X, et al. Platelet distribution width correlates with prognosis of non-small cell lung cancer. Sci Rep. 2017;7(1):3456. doi:10.1038/s41598-017-03772-z28615714
  • Darvall JN, Gregorevic KJ, Story DA, Hubbard RE, Lim WK. Frailty indexes in perioperative and critical care: A systematic review. Arch Gerontol Geriatr. 2018;79:88–96. doi:10.1016/j.archger.2018.08.00630153605
  • Burn R, Hubbard RE, Scrase RJ, et al. A frailty index derived from a standardized comprehensive geriatric assessment predicts mortality and aged residential care admission. BMC Geriatr. 2018;18(1):319. doi:10.1186/s12877-018-1016-830587158